Shopping Cart
Remove All
Your shopping cart is currently empty
SR12418 is a specific synthetic ligand for REV-ERB, demonstrating binding affinity for both REV-ERBα (IC50 = 68 nM) and REV-ERBβ (IC50 = 119 nM) in TR-FRET assays. SR12418 inhibits IL-17A expression in EL4 cells and suppresses TH17 cell differentiation, making it suitable for studies on experimental autoimmune encephalomyelitis (EAE) and colitis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $71 | - | In Stock | |
| 2 mg | $98 | - | In Stock | |
| 5 mg | $172 | - | In Stock | |
| 10 mg | $289 | - | In Stock | |
| 25 mg | $579 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $183 | - | In Stock |
| Description | SR12418 is a specific synthetic ligand for REV-ERB, demonstrating binding affinity for both REV-ERBα (IC50 = 68 nM) and REV-ERBβ (IC50 = 119 nM) in TR-FRET assays. SR12418 inhibits IL-17A expression in EL4 cells and suppresses TH17 cell differentiation, making it suitable for studies on experimental autoimmune encephalomyelitis (EAE) and colitis. |
| Targets&IC50 | REV-ERBβ:119 nM, REV-ERBα:68 nM |
| In vitro | SR12418 at a concentration of 5 μM for 96 hours can inhibit the growth of TH17 cells [1]. Under TH17 polarization induction conditions, SR12418 (5 and 10 μM, 4 days) can suppress cell differentiation [1]. |
| In vivo | SR12418 (50 mg/kg, intraperitoneal injection, twice daily) can inhibit the onset and disease severity of experimental autoimmune encephalomyelitis (EAE) [1]. Starting from day 18 post-immunization, SR12418 (50 mg/kg, intraperitoneal injection, twice daily) demonstrates therapeutic effects in the intervention study of relapsing-remitting experimental autoimmune encephalomyelitis [1]. |
| Synonyms | SR-12418, SR 12418 |
| Molecular Weight | 483.57 |
| Formula | C31H30FNO3 |
| Cas No. | 1801185-08-9 |
| Smiles | C(=O)(N1[C@H](COC2=CC=C(OC(C)(C)C)C=C2)CC=3C(C1)=CC=C(F)C3)C=4C5=C(C=CC4)C=CC=C5 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (165.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.82 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.